Biden rings cancer bell
Digest more
A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to results of a drug treatment trial in men whose prostate cancer had returned.
Researchers have discovered that the mRNA technology used in COVID-19 vaccines could also help detect and fight cancer tumours. Early studies suggest that modified mRNA can train the immune system to recognize and destroy cancer cells,
WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors.
Cooper University Hospital Cape Regional is now an approved radiation oncology site of MD Anderson Cancer Center at Cooper, the health provider announced July 2. The MD Anderson at Cooper Radiation Oncology suite offers advanced radiation treatment ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 patients worldwide and was led by Cedars-Sinai researchers.
A nationally recognized cancer treatment network with a footprint across the nation is now coming to the Slidell area.
Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more frequent screenings using technology developed at the MD Anderson Cancer Center. Dubbed the multi-cancer stratification test, or MCaST ...
News-Medical.Net on MSN
New insights into how bacteria can drive treatment resistance in oral and colorectal cancer
Researchers from The University of Texas MD Anderson Cancer Center have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer.
Feedback